New Delhi [India], October 1: Lords Mark Industries Ltd. (LMIL), a rapidly growing business group in India, won the prestigious ‘Innovation in Diagnostic Devices’ Award at the Viksit Bharat Investment Summit 2025. This event took place at the iconic House of Lords in London, organized by the Indo-European Business Forum (IEBF). The summit brought together leaders, policymakers, and entrepreneurs committed to strengthening economic ties between India, the UK, and Europe. Notably, LMIL is the first Indian medical diagnostic company to earn this award. Mr. Subodh Gupta, CEO of Lord’s Mark Microbiotech, accepted the award, recognizing the company’s innovative strides in MedTech, diagnostics, and biochemistry.
Mr. Vijay Goel, founder of IEBF, emphasized the summit’s importance. He highlighted that the Free Trade Agreements between India–UK and India–EU could unlock economic opportunities worth over £40 billion and €200 billion, respectively. Dignitaries present included prominent figures like Lords David Evans and various UK Ministers. Their presence underscored the collaborative spirit of the event.
On receiving the award, Mr. Gupta expressed pride in LMIL’s mission. He stated, “This honor at IEBF London is not just a milestone but also a confirmation of our purpose. We aim to combine science with social impact through innovations like Sickle Cell, Renalyx, and One DNA. Our goal is to align with the Prime Minister’s vision of ‘Make in India’ and ‘Atmanirbhar Bharat’ and to showcase Indian innovation globally.”
Dignitaries praised LMIL’s ambition and contributions to global public health:
- Lord David Evans highlighted LMIL’s medtech factory as a key platform for India to become a major hub for medical device innovation.
- Minister Kanishka Narayan remarked on the world-class research from LMIL’s R&D team, essential for early disease detection and treatment.
- Minister Seema Malhotra noted that LMIL’s expansion efforts are gaining international interest, positioning India’s medtech sector as a reliable destination for investment.
- Former MP Virendra Sharma recognized LMIL’s plans to create Asia’s largest facility for medtech, emphasizing innovation in India’s production landscape.
- Baroness Verma pointed out that LMIL’s intentions to list on NASDAQ or other exchanges demonstrates confidence in the future of India’s medtech industry.
This recognition lands at a pivotal time for the medtech sector, which is experiencing rapid growth. According to a recent report by ResearchAndMarkets.com, the Indian medical devices market is projected to reach $24 billion by 2024, growing at a rate of 15.8% annually. This growth reflects a broader trend where countries are increasingly focusing on healthcare innovation to improve public health outcomes. The contributions of companies like LMIL are essential for such advancements.
Overall, LMIL’s award is more than just an accolade; it’s a testament to India’s growing influence in the global healthcare landscape. As they strive for innovation, the world watches closely.
